Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yusuf Yazici, M.D.
Biosplice Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Phoenix, Arizona, United States
- Research Site
Phoenix, Arizona, United States
- Research Site
Canoga Park, California, United States
- Research Site
Carmichael, California, United States
- Research Site
La Mesa, California, United States
- Research Site
Edgewater, Florida, United States
- Research Site
Miami, Florida, United States
- Research Site
Woodstock, Georgia, United States
- Research Site
Kansas City, Missouri, United States
- Research Site
Albuquerque, New Mexico, United States
- Research Site
Cincinnati, Ohio, United States
- Research Site
Charleston, South Carolina, United States
- Research Site
San Angelo, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2018
- Primary completion
- 18 Sept 2020
- Completion
- 18 Aug 2021
- Last update posted
- 12 Jan 2026
- Registered enrollment
- 101
- Registry id
- NCT03727022
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.